SUBJECTS : Enzymology | Cell Biology | Chemical Biology | Microbiology | Physiology | Pharmacolog
LATEST MANUSCRIPTS IN Journal of Enzyme Inhibition and Medicinal Chemistry
- Mateusz Olszewski, Maryna Stasevych, Viktor Zvarych, Natalia Maciejewska. 9,10-Dioxoanthracenyldithiocarbamates effectively inhibit the proliferation of non-small cell lung cancer by targeting multiple protein tyrosine kinases. Journal of enzyme inhibition and medicinal chemistry. 2024, 39 (1): 2284113
Cited : 0Read More - Hao Zhou, Mengjiao Li, Hui Liu, Zheng Liu, Xuekun Wang, Shiben Wang. Design, synthesis, and biological evaluation of piperazine derivatives involved in the 5-HTR/BDNF/PKA pathway. Journal of enzyme inhibition and medicinal chemistry. 2024, 39 (1): 2286183Cited : 0Read More
- Lijie Sima, Zhongyuan Wang, Ling Yu, Youli Hou, Dongsheng Zhao, Bilan Luo, Weike Liao, Xinfu Liu. Discovery of LAH-1 as potent c-Met inhibitor for the treatment of non-small cell lung cancer. Journal of enzyme inhibition and medicinal chemistry. 2024, 39 (1): 2286435Cited : 1Read More
- Yusuf Akbaba, Fatma Necmiye Kacı, Mehmet Enes Arslan, Süleyman Göksü, Adil Mardinoğlu, Hasan Türkez. Novel tetrahydronaphthalen-1-yl-phenethyl ureas: synthesis and dual antibacterial-anticancer activities. Journal of enzyme inhibition and medicinal chemistry. 2024, 39 (1): 2286925Cited : 0Read More
- Kaitlyn N Alcorn, Isabelle A Oberhauser, Matthew D Politeski, Todd J Eckroat. Evaluation of -alkyl isatins and indoles as acetylcholinesterase and butyrylcholinesterase inhibitors. Journal of enzyme inhibition and medicinal chemistry. 2024, 39 (1): 2286935Cited : 0Read More
- Chao Wang, Yujing Zhang, Shanbo Yang, Lingyu Shi, Yutao Xiu, Yudong Wu, Hongfei Jiang. 3-aryl-4-(3,4,5-trimethoxyphenyl)pyridines inhibit tubulin polymerisation and act as anticancer agents. Journal of enzyme inhibition and medicinal chemistry. 2024, 39 (1): 2286939Cited : 2Read More
- Shiu-Wen Huang, Ming Jen Hsu, Hsiu-Chen Chen, Rita Meleddu, Simona Distinto, Elias Maccioni, Filippo Cottiglia. Suppression of lipopolysaccharide-induced COX-2 expression via p38MAPK, JNK, and C/EBPβ phosphorylation inhibition by furomagydarin A, a benzofuran glycoside from . Journal of enzyme inhibition and medicinal chemistry. 2024, 39 (1): 2287420Cited : 0Read More
- Pengming Pan, Dengbo Ji, Zhongjun Li, Xiangbao Meng. Design and synthesis of doublecortin-like kinase 1 inhibitors and their bioactivity evaluation. Journal of enzyme inhibition and medicinal chemistry. 2024, 39 (1): 2287990Cited : 0Read More
- Mohammad Altamimi, Saeed Ali Syed, Burak Tuzun, Mohammad Rashid Alhazani, Osamah Alnemer, Ahmed Bari. Synthesis biological evaluation and molecular docking of isatin hybrids as anti-cancer and anti-microbial agents. Journal of enzyme inhibition and medicinal chemistry. 2024, 39 (1): 2288548Cited : 3Read More
- Wen-Sheng Tzeng, Wei-Lin Teng, Pao-Hsien Huang, Feng-Lin Yen, Yow-Ling Shiue. Anti-cancer activity and cellular uptake of 7,3',4'- and 7,8,4'-trihydroxyisoflavone in HepG2 cells under hypoxic conditions. Journal of enzyme inhibition and medicinal chemistry. 2024, 39 (1): 2288806Cited : 0Read More
- Keting Li, Wenshu Hu, Yingjie Wang, Wenxing Chen, Hongmei Wen, Jian Liu, Wei Li, Bo Wang. Searching for novel MDM2/MDMX dual inhibitors through a drug repurposing approach. Journal of enzyme inhibition and medicinal chemistry. 2024, 39 (1): 2288810Cited : 0Read More
- Zorana Ferjancic, Filip Bihelovic, Bojan Vulovic, Radomir Matovic, Milena Trmcic, Aleksandar Jankovic, Milos Pavlovic, Filip Djurkovic, Radivoje Prodanovic, Aleksandra Djurdjevic Djelmas, Nevena Kalicanin, Mario Zlatovic, Dusan Sladic, Thomas Vallet, Marco Vignuzzi, Radomir N Saicic. Development of iminosugar-based glycosidase inhibitors as drug candidates for SARS-CoV-2 virus via molecular modelling and in vitro studies. Journal of enzyme inhibition and medicinal chemistry. 2024, 39 (1): 2289007Cited : 1Read More
- Xing Jin, Yuting Wang, Jing Chen, Miaomiao Niu, Yang Yang, Qiaoxuan Zhang, Guangyu Bao. Novel dual-targeting inhibitors of NSD2 and HDAC2 for the treatment of liver cancer: structure-based virtual screening, molecular dynamics simulation, and and biological activity evaluations. Journal of enzyme inhibition and medicinal chemistry. 2024, 39 (1): 2289355Cited : 1Read More
- Chunqiong Li, Quanjun Yang, Li Zhang. Identification of putative allosteric inhibitors of BCKDK via virtual screening and biological evaluation. Journal of enzyme inhibition and medicinal chemistry. 2024, 39 (1): 2290458Cited : 0Read More
- Karol Biernacki, Olga Ciupak, Mateusz Daśko, Janusz Rachon, Damian Flis, Justyna Budka, Iwona Inkielewicz-Stępniak, Anna Czaja, Janusz Rak, Sebastian Demkowicz. Development of potent and effective SARS-CoV-2 main protease inhibitors based on maleimide analogs for the potential treatment of COVID-19. Journal of enzyme inhibition and medicinal chemistry. 2024, 39 (1): 2290910Cited : 1Read More
